Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Tourmaline Bio ( (TRML) ) has provided an announcement.
Dr. Yung Chyung has announced his resignation as Chief Medical Officer of Tourmaline Bio, Inc., effective October 31, 2024, to pursue a new opportunity. He will aid in the transition until his departure and the company is thankful for his service since August 2022. The search for his successor is underway, with the departure being amicable and unrelated to any internal disagreements.
See more data about TRML stock on TipRanks’ Stock Analysis page.